Recent Applications of Hydantoins in Drug Discovery: Updates (2019~Present)
Jyoti Dnyaneshwar Palkhede, Eo-Jin Park, Om Darlami, Dongyun Shin
TL;DR
This review summarizes recent progress in using hydantoin compounds for drug discovery, highlighting their roles in treating cancer, neurological, and infectious diseases.
Contribution
The paper provides an updated overview of hydantoin-based drug discovery from 2019 to present, emphasizing novel scaffolds and therapeutic applications.
Findings
Hydantoins have shown success as kinase inhibitors, androgen receptor antagonists, and metalloprotease inhibitors.
Novel hybrid scaffolds like catechol–hydantoins and spirocyclic thiohydantoins have produced potent anticancer and antiviral leads.
Compounds like BAY-9835 and GLPG1972 demonstrate clinical potential in cardiovascular and osteoarthritic conditions.
Abstract
Hydantoins, exemplified by the imidazolidine-2,4-dione core, are privileged scaffolds in medicinal chemistry due to their compact structure, versatile hydrogen-bonding capacity, ability to fine-tune physicochemical properties for drug-like molecules, and potential to engage a diverse array of biological targets. This review highlights major advances in hydantoin-based drug discovery since 2019, emphasizing their evolving applications in oncology; neurology; infectious diseases; and cardiovascular, metabolic, and immune disorders. Recent studies demonstrate their success as kinase inhibitors, androgen receptor antagonists, and metalloprotease inhibitors, and emerging roles in modulating sterol isomerase, glycogen synthase kinase-3β, and ADAMTS family enzymes. Novel hybrid scaffolds—such as catechol–hydantoins, β-carboline–hydantoins, and spirocyclic thiohydantoins—have yielded potent and…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
Figure 16
Figure 17
Figure 18
Figure 19
Figure 20
Figure 21
Figure 22
Figure 23
Figure 24
Figure 25
Figure 26
Figure 27
Figure 28
Figure 29
Figure 30
Figure 31
Figure 32
Figure 33
Figure 34
Figure 35
Figure 36
Figure 37
Figure 38
Figure 39
Figure 40
Figure 41
Figure 42
Figure 43
Figure 44
Figure 45
Figure 46
Figure 47
Figure 48Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChemical Synthesis and Analysis · Synthesis of heterocyclic compounds · Ferrocene Chemistry and Applications